- Home
- HTH vs PTGX Comparison
HTH vs PTGX Comparison
Compare HTH & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTH
- PTGX
- Stock Information
- Founded
- HTH 1998
- PTGX 2006
- Country
- HTH United States
- PTGX United States
- Employees
- HTH N/A
- PTGX N/A
- Industry
- HTH Major Banks
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- HTH Finance
- PTGX Health Care
- Exchange
- HTH Nasdaq
- PTGX Nasdaq
- Market Cap
- HTH 1.9B
- PTGX 3.3B
- IPO Year
- HTH 2004
- PTGX 2016
- Fundamental
- Price
- HTH $31.16
- PTGX $55.23
- Analyst Decision
- HTH Hold
- PTGX Strong Buy
- Analyst Count
- HTH 2
- PTGX 9
- Target Price
- HTH $33.00
- PTGX $67.11
- AVG Volume (30 Days)
- HTH 450.3K
- PTGX 925.2K
- Earning Date
- HTH 07-24-2025
- PTGX 08-05-2025
- Dividend Yield
- HTH 2.31%
- PTGX N/A
- EPS Growth
- HTH 15.07
- PTGX N/A
- EPS
- HTH 1.97
- PTGX 0.86
- Revenue
- HTH $1,208,822,000.00
- PTGX $207,801,000.00
- Revenue This Year
- HTH N/A
- PTGX N/A
- Revenue Next Year
- HTH $1.36
- PTGX $53.09
- P/E Ratio
- HTH $15.82
- PTGX $63.67
- Revenue Growth
- HTH 2.13
- PTGX N/A
- 52 Week Low
- HTH $26.67
- PTGX $32.50
- 52 Week High
- HTH $35.32
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- HTH 53.38
- PTGX 60.92
- Support Level
- HTH $30.62
- PTGX $49.38
- Resistance Level
- HTH $32.16
- PTGX $51.51
- Average True Range (ATR)
- HTH 0.50
- PTGX 2.09
- MACD
- HTH 0.01
- PTGX -0.14
- Stochastic Oscillator
- HTH 42.31
- PTGX 74.47
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.